| MEDPACE HOLDINGS DL-,01 |
| USA |
| Gesundheit |
| US58506Q1094 / A2APTV |
| 01P (Frankfurt) / MEDP (NASDAQ) |
| FRA:01P, ETR:01P, 01P:GR, NASDAQ:MEDP |
| - |
| https://www.medpace.com/ |
|
Medpace Holdings, Inc. is a global clinical research organization that provides outsourced clinical development services for biotechnology, pharmaceutical, and medical device companies. Medpace supports the full clinical trial lifecycle, from Phase I..
>Volltext.. |
| 15403.29 Mio. EUR |
| 15089.74 Mio. EUR |
| 2477.86 Mio. EUR |
| 544.32 Mio. EUR |
| 437.72 Mio. EUR |
| 15.49 EUR |
| 128.34 Mio. EUR |
| 447.69 Mio. EUR |
| 670.31 Mio. EUR |
| 0.35 |
| 28.59% |
| 21.2% |
| - |
| - |
| - |
| 1 Insider verkaufte innerhalb der letzten 30 Tage Aktien im Wert von 92.197.486 Euro. |
| MEDPACE |
| 22.10.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|